Cytokinetics Inc (CYTK): Mark Lampert’s Biotechnology Value Fund Loads Up On More Shares

Page 5 of 14

Page 5 of 14 SEC Filing
1
NAME OF REPORTING PERSON
BVF Partners OS Ltd.
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
  (a) x
  (b) o
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5
SOLE VOTING POWER
0 shares
6
SHARED VOTING POWER
342,985
7
SOLE DISPOSITIVE POWER
0 shares
8
SHARED DISPOSITIVE POWER
342,985
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
342,985
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
¨
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
Less than 1%
12
TYPE OF REPORTING PERSON
 
CO

Follow Cytokinetics Inc (NASDAQ:CYTK)

Page 5 of 14